Bloomage BioTechnology Corporation Limited ("the Company ") (together with its subsidiaries, the "Group") was incorporated in the Cayman Islands on 3 April 2006. It holds the entire issued share capitals of two companies – Valuerank Holdings Limited and Farstar Enterprises Limited – both of which were incorporated in the British Virgin Islands.

Bloomage BioTechnology Corporation Limited owns 91.5% equity interest in Shandong Freda Bio-chemicals Co., Ltd ("Shandong Freda") indirectly. Established in 2000 and located in the Jinan High-tech Development Zone, Shandong Freda is a sino-foreign cooperative joint venture enterprise. With the commitment to excellence, Shandong Freda has made continuous efforts in research, development and sale of hyaluronic acid. Supported by a strong R&D team, world-class hardware facilities, stringent quality inspection standards, commitment to innovation and modern management concepts and practices, Shandong Freda has developed into a vibrant enterprise with wealth of expertise and uncompromising spirit. Today, Shandong Freda is a hyaluronic acid manufacturing enterprise in the PRC and the world.

Hyaluronic acid (HA), the key product of the Group, is a kind of glycosaminoglycans used mainly in pharmaceutical products, cosmetics and health supplement. It is deemed as a "natural moisturizing agent" for cosmetics products while in pharmaceutical aspects, it is used as viscoelastic agent used in eye surgery, and also applied in injection for the orthopedic treatment, eye drops, post-operative anti-adhesion, anti-wrinkle and anti-ageing cosmetic procedure and contact lens care lotions, etc. In recent years, demands for health supplement products with HA have increased since HA has cosmetic function, nutritional value and ability to improve joint function.

The Group is supported by a research team led by a leading national expert in research and development of micro-organic fermentation technology and biochemical medicine production, as well as advanced machineries and equipment. Using HA as its core of the technology and development plan, the Group has continued to focus on the future development and innovate from time to time. The quality of HA from the Group used in pharmaceutical products has attained the standard of the Europe Pharmacopoeia Reference Standard.

With reference to the requirements of ISO9001 and Good Manufacturing Practice (GMP), the Group has compiled its own quality standards for production that covers all basic production processes and entails comprehensive and standardized recording of quality assurance procedures. For the different HA products, the Group has specified corresponding production flow and technical requirements and standards for compliance monitoring, tracking and documentation. Operations are subject to multiple inspections in order to ensure production is under full control. Regarding its production facilities, Shandong Freda is equipped with advanced production equipment and measurement apparatuses with national standard and has established its clean rooms of grade 100 and 10,000 according to GMP standards. Furthermore, the Group has set up a set of stringent management system for the purification zone installed with production facilities designed with reference also to GMP requirements. From fermentation and purification processes to packaging to storage, the Group has demonstrated its expertise and dedication to excellence.

The Group has been active in establishing a sales management structure that is able to cater for the needs of the market. By consolidating market resources, the Group has built a sales network and promotional platform which facilitates corporate development. Its HA products are saled to in the domestic market and are exported to overseas countries and regions such as the U.S., Japan, the European Union, Canada, Brazil, Korea and Taiwan. Through cooperating with a number of domestic and overseas pharmaceutical, healthcare and cosmetic product enterprises, the Group has gained extensive experience which enables it to provide quality products and professional services to its customers in the cosmetics, food and pharmaceutical sectors in relation to HA use.

The corporate culture of the Group is summarized in the proverb "Open Stream Delivers Excellence". Abiding by the management concept of having the customer in heart, it continues to develop with improvement in its production technology and enhancement in product quality. With our focus on the market and customers' needs, we are able to provide quality products as well as mature and systemic solutions and comprehensive services. We are dedicated to create higher value for our customers, as well as building a workforce with high-caliber personnel, which enables us to maximize our value both at the corporate level and individual staff level.